173 related articles for article (PubMed ID: 22553397)
1. Macrophage secretory products induce an inflammatory phenotype in hepatocytes.
Melino M; Gadd VL; Walker GV; Skoien R; Barrie HD; Jothimani D; Horsfall L; Jones A; Sweet MJ; Thomas GP; Clouston AD; Jonsson JR; Powell EE
World J Gastroenterol; 2012 Apr; 18(15):1732-44. PubMed ID: 22553397
[TBL] [Abstract][Full Text] [Related]
2. Induction of lipocalin-2 expression in acute and chronic experimental liver injury moderated by pro-inflammatory cytokines interleukin-1β through nuclear factor-κB activation.
Borkham-Kamphorst E; Drews F; Weiskirchen R
Liver Int; 2011 May; 31(5):656-65. PubMed ID: 21457438
[TBL] [Abstract][Full Text] [Related]
3. Portal, but not lobular, macrophages express matrix metalloproteinase-9: association with the ductular reaction and fibrosis in chronic hepatitis C.
Gadd VL; Melino M; Roy S; Horsfall L; O'Rourke P; Williams MR; Irvine KM; Sweet MJ; Jonsson JR; Clouston AD; Powell EE
Liver Int; 2013 Apr; 33(4):569-79. PubMed ID: 23240894
[TBL] [Abstract][Full Text] [Related]
4. Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages.
Soldano S; Pizzorni C; Paolino S; Trombetta AC; Montagna P; Brizzolara R; Ruaro B; Sulli A; Cutolo M
PLoS One; 2016; 11(11):e0166433. PubMed ID: 27846260
[TBL] [Abstract][Full Text] [Related]
5. Senescent human hepatocytes express a unique secretory phenotype and promote macrophage migration.
Irvine KM; Skoien R; Bokil NJ; Melino M; Thomas GP; Loo D; Gabrielli B; Hill MM; Sweet MJ; Clouston AD; Powell EE
World J Gastroenterol; 2014 Dec; 20(47):17851-62. PubMed ID: 25548483
[TBL] [Abstract][Full Text] [Related]
6. Increased urinary lipocalin-2 reflects matrix metalloproteinase-9 activity in chronic hepatitis C with hepatic fibrosis.
Kim JW; Lee SH; Jeong SH; Kim H; Ahn KS; Cho JY; Yoon YS; Han HS
Tohoku J Exp Med; 2010 Dec; 222(4):319-27. PubMed ID: 21150136
[TBL] [Abstract][Full Text] [Related]
7. Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans.
Catalán V; Gómez-Ambrosi J; Rodríguez A; Ramírez B; Silva C; Rotellar F; Gil MJ; Cienfuegos JA; Salvador J; Frühbeck G
J Mol Med (Berl); 2009 Aug; 87(8):803-13. PubMed ID: 19466389
[TBL] [Abstract][Full Text] [Related]
8. New Mechanism of Hepatic Fibrogenesis: Hepatitis C Virus Infection Induces Transforming Growth Factor β1 Production through Glucose-Regulated Protein 94.
Jee MH; Hong KY; Park JH; Lee JS; Kim HS; Lee SH; Jang SK
J Virol; 2015 Dec; 90(6):3044-55. PubMed ID: 26719248
[TBL] [Abstract][Full Text] [Related]
9. The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients.
Fernández CA; Yan L; Louis G; Yang J; Kutok JL; Moses MA
Clin Cancer Res; 2005 Aug; 11(15):5390-5. PubMed ID: 16061852
[TBL] [Abstract][Full Text] [Related]
10. Renal tubular fluid shear stress facilitates monocyte activation toward inflammatory macrophages.
Miravète M; Dissard R; Klein J; Gonzalez J; Caubet C; Pecher C; Pipy B; Bascands JL; Mercier-Bonin M; Schanstra JP; Buffin-Meyer B
Am J Physiol Renal Physiol; 2012 Jun; 302(11):F1409-17. PubMed ID: 22419690
[TBL] [Abstract][Full Text] [Related]
11. Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells.
Chong LW; Hsu YC; Lee TF; Lin Y; Chiu YT; Yang KC; Wu JC; Huang YT
BMC Gastroenterol; 2015 Feb; 15():22. PubMed ID: 25886887
[TBL] [Abstract][Full Text] [Related]
12. Cooperation of liver cells in health and disease.
Kmieć Z
Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C Virus-Induced Monocyte Differentiation Into Polarized M2 Macrophages Promotes Stellate Cell Activation via TGF-β.
Saha B; Kodys K; Szabo G
Cell Mol Gastroenterol Hepatol; 2016 May; 2(3):302-316.e8. PubMed ID: 28090562
[TBL] [Abstract][Full Text] [Related]
14. Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer.
Kubben FJ; Sier CF; Hawinkels LJ; Tschesche H; van Duijn W; Zuidwijk K; van der Reijden JJ; Hanemaaijer R; Griffioen G; Lamers CB; Verspaget HW
Eur J Cancer; 2007 Aug; 43(12):1869-76. PubMed ID: 17604154
[TBL] [Abstract][Full Text] [Related]
15. LIPOCALIN-2 is a major acute-phase protein in a rat and mouse model of sterile abscess.
Sultan S; Pascucci M; Ahmad S; Malik IA; Bianchi A; Ramadori P; Ahmad G; Ramadori G
Shock; 2012 Feb; 37(2):191-6. PubMed ID: 22249220
[TBL] [Abstract][Full Text] [Related]
16. Lipocalin 2-mediated growth suppression is evident in human erythroid and monocyte/macrophage lineage cells.
Miharada K; Hiroyama T; Sudo K; Danjo I; Nagasawa T; Nakamura Y
J Cell Physiol; 2008 May; 215(2):526-37. PubMed ID: 18064607
[TBL] [Abstract][Full Text] [Related]
17. Conditioned medium from stimulated macrophages inhibits growth but induces an inflammatory phenotype in breast cancer cells.
Song W; Thakor P; Vesey DA; Gobe GC; Morais C
Biomed Pharmacother; 2018 Oct; 106():247-254. PubMed ID: 29966967
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of platelet derived growth factor-BB, transforming growth factor-beta1, matrix metalloproteinase-1, and tissue inhibitor of matrix metalloproteinase-1 in serum and peripheral blood mononuclear cells for hepatic fibrosis.
Zhang BB; Cai WM; Weng HL; Hu ZR; Lu J; Zheng M; Liu RH
World J Gastroenterol; 2003 Nov; 9(11):2490-6. PubMed ID: 14606082
[TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in mesothelial cells and their regulation by transforming growth factor-beta1.
Ma C; Tarnuzzer RW; Chegini N
Wound Repair Regen; 1999; 7(6):477-85. PubMed ID: 10633007
[TBL] [Abstract][Full Text] [Related]
20. Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes.
Hirsova P; Ibrahim SH; Krishnan A; Verma VK; Bronk SF; Werneburg NW; Charlton MR; Shah VH; Malhi H; Gores GJ
Gastroenterology; 2016 Apr; 150(4):956-67. PubMed ID: 26764184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
